CD19 is a surface marker of B lymphocytes and is widely expressed in leukemia and lymphoma derived from the B-cell lineage, while CD3 is a critical marker expressed on the surface of cytotoxic T lymphocytes (26). This evidence concerns the gene CD19 and leukemia.